Gregory Frost Net Worth & Insider Trades

Gregory Frost - VP and Chief Scientific Off., Halozyme Therapeutics Inc

As of February 7, 2007

What is Gregory Frost's Net Worth?

The current estimated net worth of Halozyme Therapeutics Inc's VP and Chief Scientific Off., Gregory Frost, is estimated to be about $15.54M . Gregory Frost owns about 3,063,779 units of Halozyme Therapeutics Inc common stock. In the last 2 years at Halozyme Therapeutics Inc, Gregory Frost has sold an estimated value of $0 worth.

What is Gregory Frost's Past Insider Trading?

Gregory Frost's largest purchase order was 5,000 units , worth over $8.45K on August 23, 2005. In total, Gregory Frost has made about 3 transactions over 2 years of their time at Halozyme Therapeutics Inc. Gregory Frost usually trades in February, January and August, with the busiest year in 2005.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gregory Frost

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Gregory Frost's' Mailing Address?

  • Mailing address is 11588 Sorrento Valley Road, Suite 17 San Diego CA 92121 CA

What are Halozyme Therapeutics Inc's Past Insider Trades?

Halozyme Therapeutics Inc's most recent insider trade came on September 17, 2007 by Randal J Kirk who bought 431,426 units worth $3.75M . In the last 2 years, insiders at Halozyme Therapeutics Inc have sold an estimated value of $3.96M and bought an estimated value of $43.11M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Kenneth J Kelley, Director,  Randal J Kirk, Director,  and John S. Patton, Director .

HALOZYME THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...